User:EthosNap/Contribution

Prevention
Measles is highly contagious, since the damage of epithelial cells in the upper respiratory tract caused by the virus produces a cough reflex that spreads aerosols. Health care centers, travel centers, and large gatherings are all recognized hotspots for the transmission of Measles. Although endemic transmission still continues around the world, current efforts for global vaccination have greatly lowered Measles cases. In order to completely eliminate Measles worldwide, over 93% of the population must be vaccinated. Case-based surveillance is also vital for eradication.

All current Measles vaccines are live attenuated. It is produced in chick embryo tissue culture and can be administered on its own in the form of subcutaneous injection, but is more commonly delivered as a combination vaccine with mumps and rubella (MMR). The vaccine must contain at least 1,000 TCID50, according to WHO. All children over age one are recommended to get two doses of Measles vaccine, at least 4 weeks apart. One injection of vaccine after age one usually produces immunity, while two injections are almost completely effective. 2 to 5% of children will not produce immunity after the first dose, while studies have shown that 99% of children will produce immunity after the second dose. The duration of immunity after vaccination is lifelong. Travelers, students, health care workers, and individuals exposed to a Measles outbreak are also all recommended to get vaccinated for Measles.

ERDRP-0519 and Inosine pranobex are both antiviral drugs for Measles.